デジタルヘルス市場(製品:ヘルスケア情報システム、ウェアラブルデバイス、コンポーネント:ソフトウェア、ハードウェア、サービス) - 世界の産業分析、規模、シェア、成長、動向、予測、2023-2031年Digital Health Market (Product: Healthcare Information Systems and Wearable Devices; and Component: Software, Hardware, and Services) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031 デジタルヘルス市場 - レポートの範囲 TMRの調査レポート「世界のデジタルヘルス市場」は、2023年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリーデジタルヘルス市場 - レポートの範囲TMRの調査レポート「世界のデジタルヘルス市場」は、2023年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会を調査しています。当レポートでは、2023年を基準年、2031年を予測年として、2017年から2031年にかけての世界のデジタルヘルス市場の収益を掲載しています。また、2023年から2031年までの世界のデジタルヘルス市場の複合年間成長率(CAGR %)も掲載しています。 本レポートは広範な調査を経て作成されています。主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。二次調査では、デジタルヘルス市場を理解するために、主要企業の製品資料、年次報告書、プレスリリース、関連文書を参照した。 二次調査には、インターネットソース、政府機関の統計データ、ウェブサイト、業界団体なども含まれる。アナリストは、トップダウンアプローチとボトムアップアプローチを組み合わせて、世界のデジタルヘルス市場の様々な属性を調査しました。 本レポートには、調査範囲に含まれる様々なセグメントの成長動向のスナップショットとともに、詳細なエグゼクティブサマリーが含まれています。さらに、世界のデジタルヘルス市場における競争ダイナミクスの変化にも光を当てています。これらは、既存の市場プレイヤーだけでなく、世界のデジタルヘルス市場への参入に関心のある企業にとっても貴重なツールとなります。 本レポートでは、世界のデジタルヘルス市場の競争環境について掘り下げています。世界のデジタルヘルス市場で事業を展開する主要企業が特定され、これらの各企業が様々な属性の観点からプロファイリングされています。会社概要、財務状況、最近の動向、SWOTは、本レポートで紹介されている世界のデジタルヘルス市場のプレーヤーの属性です。 デジタルヘルスの世界市場レポートが回答した主要な質問 - 予測期間中の全地域におけるデジタルヘルスが生み出す売上高/収益は? - 世界のデジタルヘルス市場におけるビジネスチャンスは? - 市場における主な促進要因、阻害要因、機会、脅威は何か? - 予測期間中に最も速いCAGRで拡大する地域市場はどこか? - 2031年に世界で最も高い収益を上げると予測されるセグメントは? - 予測期間中に最も高いCAGRで拡大すると予測されるセグメントは? - 世界市場で事業を展開する各企業の市場ポジションは? デジタルヘルス市場 - 調査目的と調査アプローチ 世界のデジタルヘルス市場に関する包括的なレポートは、概要から始まり、調査範囲と目的が続きます。本レポートでは、本調査の目的、市場で事業を展開する主要ベンダーと流通業者、製品承認のための規制シナリオについて詳細に解説しています。 本レポートは、読みやすさを考慮し、各セクションを章ごとに分割したレイアウトになっています。本レポートは、グラフや表が適切に散りばめられた網羅的なコレクションで構成されています。主要セグメントの実績値と予測値を図式化し、読者に視覚的に訴える。また、過去と予測期間末の主要セグメントの市場シェアを比較することもできる。 本レポートでは、世界のデジタルヘルス市場を製品、エンドユーザー、地域の観点から分析しています。各基準の主要セグメントを詳細に調査し、2031年末時点の各セグメント市場シェアを掲載しています。このような貴重な洞察により、市場関係者は世界のデジタルヘルス市場への投資について、十分な情報に基づいたビジネス上の意思決定を行うことができます。 目次1. Preface1.1. Market Definition and Scope 1.2. Market Segmentation 1.3. Key Research Objectives 1.4. Research Highlights 2. Assumptions and Research Methodology 3. Executive Summary: Global Digital Health Market 4. Market Overview 4.1. Introduction 4.1.1. Segment Definition 4.2. Overview 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. Global Digital Health Market Analysis and Forecast, 2017-2031 4.4.1. Market Revenue Projections (US$ Bn) 5. Key Insights 5.1. Trends 5.1.1. Increase in Adoption of Cloud-based Systems 5.1.2. Virtualization Technologies and Technological Advancements Add New Dimensions to Healthcare IT 5.2. Digital Therapeutic Business, Opportunities, and Entry Barriers for New Market Entrants 5.3. Qualitative Information on Business Models in Digital Health Market 5.4. Traditional Business Model: Challenges to Traditional Business Model 5.5. New Digital Health Business Model 5.6. Adoption of Digital Healthcare, by End-users 5.7. Impact Factor for Digital Therapeutic Demand 5.8. Global Healthcare Expenditure, by Major Countries 5.9. Digital Medicine Business Model 5.10. Factors Increasing Traction of Digital Therapeutic Products 5.10.1. Healthcare Costs 5.10.2. Value-based Payment Models 5.10.3. Venture Funding 5.10.4. Others 6. Global Digital Health Market Analysis and Forecast, by Product 6.1. Introduction & Definition 6.2. Key Findings/Developments 6.3. Market Value Forecast, by Product, 2017-2031 6.3.1. Healthcare Information Systems 6.3.1.1. Clinical Solutions 6.3.1.1.1. EHR/EMR 6.3.1.1.2. Clinical Decision Support System (CDSS) 6.3.1.1.3. Computerized Physician Order Entry (CPOE) 6.3.1.1.4. mHealth 6.3.1.1.4.1. Connected Medical Devices 6.3.1.1.4.2. mHealth Components 6.3.1.1.4.2.1. Fitness App 6.3.1.1.4.2.2. Medical Reference 6.3.1.1.4.2.3. Fitness App 6.3.1.1.4.2.4. Wellness 6.3.1.1.4.2.5. Medical Condition Management 6.3.1.1.4.2.6. Nutrition 6.3.1.1.4.2.7. Remote Consultation 6.3.1.1.4.2.8. Reminders and Alerts 6.3.1.1.4.2.9. Others 6.3.1.1.5. Telehealth 6.3.1.1.6. Population Health Management 6.3.1.1.7. Others 6.3.1.2. Non-clinical Solutions 6.3.2. Wearable Devices 6.3.2.1. Diagnostic and Monitoring Devices 6.3.2.2. Digital Therapeutic Devices 6.3.2.2.1. Pain Management Devices 6.3.2.2.2. Rehabilitation Devices 6.3.2.2.3. Respiratory Therapy Devices 6.3.2.2.4. Insulin Pumps 6.4. Market Attractiveness Analysis, by Product 7. Global Digital Health Market Analysis and Forecast, by Component 7.1. Introduction & Definition 7.2. Key Findings/Developments 7.3. Market Value Forecast, by Component, 2017-2031 7.3.1. Software 7.3.2. Hardware 7.3.3. Services 7.4. Market Attractiveness Analysis, by Component 8. Global Digital Health Market Analysis and Forecast, by End-user 8.1. Introduction & Definition 8.2. Key Findings/Developments 8.3. Market Value Forecast, by End-user, 2017-2031 8.3.1. B2C 8.3.1.1. Patients 8.3.1.2. Caregivers 8.3.2. B2B 8.3.2.1. Providers 8.3.2.2. Payers 8.3.2.3. Employers 8.3.2.4. Pharmaceutical Companies 8.3.2.5. Others 8.4. Market Attractiveness Analysis, by End-user 9. Global Digital Health Market Analysis and Forecast, by Region 9.1. Key Findings 9.2. Market Value Forecast, by Region, 2017-2031 9.2.1. North America 9.2.2. Europe 9.2.3. Asia Pacific 9.2.4. Latin America 9.2.5. Middle East & Africa 9.3. Market Attractiveness Analysis, by Region 10. North America Digital Health Market Analysis and Forecast 10.1. Introduction 10.1.1. Key Findings 10.2. Market Value Forecast, by Product, 2017-2031 10.2.1. Healthcare Information Systems 10.2.1.1. Clinical Solutions 10.2.1.1.1. EHR/EMR 10.2.1.1.2. Clinical Decision Support System (CDSS) 10.2.1.1.3. Computerized Physician Order Entry (CPOE) 10.2.1.1.4. mHealth 10.2.1.1.4.1. Connected Medical Devices 10.2.1.1.4.2. mHealth Components 10.2.1.1.4.2.1. Fitness App 10.2.1.1.4.2.2. Medical Reference 10.2.1.1.4.2.3. Fitness App 10.2.1.1.4.2.4. Wellness 10.2.1.1.4.2.5. Medical Condition Management 10.2.1.1.4.2.6. Nutrition 10.2.1.1.4.2.7. Remote Consultation 10.2.1.1.4.2.8. Reminders and Alerts 10.2.1.1.4.2.9. Others 10.2.1.1.5. Telehealth 10.2.1.1.6. Population Health Management 10.2.1.1.7. Others 10.2.1.2. Non-clinical Solutions 10.2.2. Wearable Devices 10.2.2.1. Diagnostic and Monitoring Devices 10.2.2.2. Digital Therapeutic Devices 10.2.2.2.1. Pain Management Devices 10.2.2.2.2. Rehabilitation Devices 10.2.2.2.3. Respiratory Therapy Devices 10.2.2.2.4. Insulin Pumps 10.3. Market Value Forecast, by Component, 2017-2031 10.3.1. Software 10.3.2. Hardware 10.3.3. Services 10.4. Market Value Forecast, by End-user, 2017-2031 10.4.1. B2C 10.4.1.1. Patients 10.4.1.2. Caregivers 10.4.2. B2B 10.4.2.1. Providers 10.4.2.2. Payers 10.4.2.3. Employers 10.4.2.4. Pharmaceutical Companies 10.4.2.5. Others 10.5. Market Value Forecast, by Country, 2017-2031 10.5.1. U.S. 10.5.2. Canada 10.6. Market Attractiveness Analysis 10.6.1. By Product 10.6.2. By Component 10.6.3. By End-user 10.6.4. By Country 11. Europe Digital Health Market Analysis and Forecast 11.1. Introduction 11.1.1. Key Findings 11.2. Market Value Forecast, by Product, 2017-2031 11.2.1. Healthcare Information Systems 11.2.1.1. Clinical Solutions 11.2.1.1.1. EHR/EMR 11.2.1.1.2. Clinical Decision Support System (CDSS) 11.2.1.1.3. Computerized Physician Order Entry (CPOE) 11.2.1.1.4. mHealth 11.2.1.1.4.1. Connected Medical Devices 11.2.1.1.4.2. mHealth Components 11.2.1.1.4.2.1. Fitness App 11.2.1.1.4.2.2. Medical Reference 11.2.1.1.4.2.3. Fitness App 11.2.1.1.4.2.4. Wellness 11.2.1.1.4.2.5. Medical Condition Management 11.2.1.1.4.2.6. Nutrition 11.2.1.1.4.2.7. Remote Consultation 11.2.1.1.4.2.8. Reminders and Alerts 11.2.1.1.4.2.9. Others 11.2.1.1.5. Telehealth 11.2.1.1.6. Population Health Management 11.2.1.1.7. Others 11.2.1.2. Non-clinical Solutions 11.2.2. Wearable Devices 11.2.2.1. Diagnostic and Monitoring Devices 11.2.2.2. Digital Therapeutic Devices 11.2.2.2.1. Pain Management Devices 11.2.2.2.2. Rehabilitation Devices 11.2.2.2.3. Respiratory Therapy Devices 11.2.2.2.4. Insulin Pumps 11.3. Market Value Forecast, by Component, 2017-2031 11.3.1. Software 11.3.2. Hardware 11.3.3. Services 11.4. Market Value Forecast, by End-user, 2017-2031 11.4.1. B2C 11.4.1.1. Patients 11.4.1.2. Caregivers 11.4.2. B2B 11.4.2.1. Providers 11.4.2.2. Payers 11.4.2.3. Employers 11.4.2.4. Pharmaceutical Companies 11.4.2.5. Others 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031 11.5.1. Germany 11.5.2. U.K. 11.5.3. France 11.5.4. Italy 11.5.5. Spain 11.5.6. Rest of Europe 11.6. Market Attractiveness Analysis 11.6.1. By Product 11.6.2. By Component 11.6.3. By End-user 11.6.4. By Country/Sub-region 12. Asia Pacific Digital Health Market Analysis and Forecast 12.1. Introduction 12.1.1. Key Findings 12.2. Market Value Forecast, by Product, 2017-2031 12.2.1. Healthcare Information Systems 12.2.1.1. Clinical Solutions 12.2.1.1.1. EHR/EMR 12.2.1.1.2. Clinical Decision Support System (CDSS) 12.2.1.1.3. Computerized Physician Order Entry (CPOE) 12.2.1.1.4. mHealth 12.2.1.1.4.1. Connected Medical Devices 12.2.1.1.4.2. mHealth Components 12.2.1.1.4.2.1. Fitness App 12.2.1.1.4.2.2. Medical Reference 12.2.1.1.4.2.3. Fitness App 12.2.1.1.4.2.4. Wellness 12.2.1.1.4.2.5. Medical Condition Management 12.2.1.1.4.2.6. Nutrition 12.2.1.1.4.2.7. Remote Consultation 12.2.1.1.4.2.8. Reminders and Alerts 12.2.1.1.4.2.9. Others 12.2.1.1.5. Telehealth 12.2.1.1.6. Population Health Management 12.2.1.1.7. Others 12.2.1.2. Non-clinical Solutions 12.2.2. Wearable Devices 12.2.2.1. Diagnostic and Monitoring Devices 12.2.2.2. Digital Therapeutic Devices 12.2.2.2.1. Pain Management Devices 12.2.2.2.2. Rehabilitation Devices 12.2.2.2.3. Respiratory Therapy Devices 12.2.2.2.4. Insulin Pumps 12.3. Market Value Forecast, by Component, 2017-2031 12.3.1. Software 12.3.2. Hardware 12.3.3. Services 12.4. Market Value Forecast, by End-user, 2017-2031 12.4.1. B2C 12.4.1.1. Patients 12.4.1.2. Caregivers 12.4.2. B2B 12.4.2.1. Providers 12.4.2.2. Payers 12.4.2.3. Employers 12.4.2.4. Pharmaceutical Companies 12.4.2.5. Others 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031 12.5.1. China 12.5.2. India 12.5.3. Japan 12.5.4. Australia & New Zealand 12.5.5. Rest of Asia Pacific 12.6. Market Attractiveness Analysis 12.6.1. By Product 12.6.2. By Component 12.6.3. By End-user 12.6.4. By Country/Sub-region 13. Latin America Digital Health Market Analysis and Forecast 13.1. Introduction 13.1.1. Key Findings 13.2. Market Value Forecast, by Product, 2017-2031 13.2.1. Healthcare Information Systems 13.2.1.1. Clinical Solutions 13.2.1.1.1. EHR/EMR 13.2.1.1.2. Clinical Decision Support System (CDSS) 13.2.1.1.3. Computerized Physician Order Entry (CPOE) 13.2.1.1.4. mHealth 13.2.1.1.4.1. Connected Medical Devices 13.2.1.1.4.2. mHealth Components 13.2.1.1.4.2.1. Fitness App 13.2.1.1.4.2.2. Medical Reference 13.2.1.1.4.2.3. Fitness App 13.2.1.1.4.2.4. Wellness 13.2.1.1.4.2.5. Medical Condition Management 13.2.1.1.4.2.6. Nutrition 13.2.1.1.4.2.7. Remote Consultation 13.2.1.1.4.2.8. Reminders and Alerts 13.2.1.1.4.2.9. Others 13.2.1.1.5. Telehealth 13.2.1.1.6. Population Health Management 13.2.1.1.7. Others 13.2.1.2. Non-clinical Solutions 13.2.2. Wearable Devices 13.2.2.1. Diagnostic and Monitoring Devices 13.2.2.2. Digital Therapeutic Devices 13.2.2.2.1. Pain Management Devices 13.2.2.2.2. Rehabilitation Devices 13.2.2.2.3. Respiratory Therapy Devices 13.2.2.2.4. Insulin Pumps 13.3. Market Value Forecast, by Component, 2017-2031 13.3.1. Software 13.3.2. Hardware 13.3.3. Services 13.4. Market Value Forecast, by End-user, 2017-2031 13.4.1. B2C 13.4.1.1. Patients 13.4.1.2. Caregivers 13.4.2. B2B 13.4.2.1. Providers 13.4.2.2. Payers 13.4.2.3. Employers 13.4.2.4. Pharmaceutical Companies 13.4.2.5. Others 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031 13.5.1. Brazil 13.5.2. Mexico 13.5.3. Rest of Latin America 13.6. Market Attractiveness Analysis 13.6.1. By Product 13.6.2. By Component 13.6.3. By End-user 13.6.4. By Country/Sub-region 14. Middle East & Africa Digital Health Market Analysis and Forecast 14.1. Introduction 14.1.1. Key Findings 14.2. Market Value Forecast, by Product, 2017-2031 14.2.1. Healthcare Information Systems 14.2.1.1. Clinical Solutions 14.2.1.1.1. EHR/EMR 14.2.1.1.2. Clinical Decision Support System (CDSS) 14.2.1.1.3. Computerized Physician Order Entry (CPOE) 14.2.1.1.4. mHealth 14.2.1.1.4.1. Connected Medical Devices 14.2.1.1.4.2. mHealth Components 14.2.1.1.4.2.1. Fitness App 14.2.1.1.4.2.2. Medical Reference 14.2.1.1.4.2.3. Fitness App 14.2.1.1.4.2.4. Wellness 14.2.1.1.4.2.5. Medical Condition Management 14.2.1.1.4.2.6. Nutrition 14.2.1.1.4.2.7. Remote Consultation 14.2.1.1.4.2.8. Reminders and Alerts 14.2.1.1.4.2.9. Others 14.2.1.1.5. Telehealth 14.2.1.1.6. Population Health Management 14.2.1.1.7. Others 14.2.1.2. Non-clinical Solutions 14.2.2. Wearable Devices 14.2.2.1. Diagnostic and Monitoring Devices 14.2.2.2. Digital Therapeutic Devices 14.2.2.2.1. Pain Management Devices 14.2.2.2.2. Rehabilitation Devices 14.2.2.2.3. Respiratory Therapy Devices 14.2.2.2.4. Insulin Pumps 14.3. Market Value Forecast, by Component, 2017-2031 14.3.1. Software 14.3.2. Hardware 14.3.3. Services 14.4. Market Value Forecast, by End-user, 2017-2031 14.4.1. B2C 14.4.1.1. Patients 14.4.1.2. Caregivers 14.4.2. B2B 14.4.2.1. Providers 14.4.2.2. Payers 14.4.2.3. Employers 14.4.2.4. Pharmaceutical Companies 14.4.2.5. Others 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031 14.5.1. GCC Countries 14.5.2. South Africa 14.5.3. Rest of Middle East & Africa 14.6. Market Attractiveness Analysis 14.6.1. By Product 14.6.2. By Component 14.6.3. By End-user 14.6.4. By Country/Sub-region 15. Competition Landscape 15.1. Market Player - Competition Matrix (by Tier and Size of Companies) 15.2. Market Share Analysis, by Company, 2022 15.3. Company Profiles 15.3.1. Agfa-Gevaert N.V. 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.1.2. Product Portfolio 15.3.1.3. Financial Overview 15.3.1.4. SWOT Analysis 15.3.1.5. Strategic Overview 15.3.2. Cerner Corporation 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.2.2. Product Portfolio 15.3.2.3. Financial Overview 15.3.2.4. SWOT Analysis 15.3.2.5. Strategic Overview 15.3.3. Allscripts Healthcare Solutions, Inc. 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.3.2. Product Portfolio 15.3.3.3. Financial Overview 15.3.3.4. SWOT Analysis 15.3.3.5. Strategic Overview 15.3.4. McKesson Corporation 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.4.2. Product Portfolio 15.3.4.3. Financial Overview 15.3.4.4. SWOT Analysis 15.3.4.5. Strategic Overview 15.3.5. Philips Healthcare 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.5.2. Product Portfolio 15.3.5.3. Financial Overview 15.3.5.4. SWOT Analysis 15.3.5.5. Strategic Overview 15.3.6. GE Healthcare 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.6.2. Product Portfolio 15.3.6.3. Financial Overview 15.3.6.4. SWOT Analysis 15.3.6.5. Strategic Overview 15.3.7. Siemens Healthineers 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.7.2. Product Portfolio 15.3.7.3. Financial Overview 15.3.7.4. SWOT Analysis 15.3.7.5. Strategic Overview 15.3.8. Epic Systems Corporation. 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.8.2. Product Portfolio 15.3.8.3. Financial Overview 15.3.8.4. SWOT Analysis 15.3.8.5. Strategic Overview 15.3.9. Merative 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.9.2. Product Portfolio 15.3.9.3. Financial Overview 15.3.9.4. SWOT Analysis 15.3.9.5. Strategic Overview 15.3.10. Alphabet Inc. 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.10.2. Product Portfolio 15.3.10.3. Financial Overview 15.3.10.4. SWOT Analysis 15.3.10.5. Strategic Overview 15.3.11. Qualcomm, Inc. 15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.11.2. Product Portfolio 15.3.11.3. Financial Overview 15.3.11.4. SWOT Analysis 15.3.11.5. Strategic Overview 15.3.12. UnitedHealth Group (Optum) 15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.12.2. Product Portfolio 15.3.12.3. Financial Overview 15.3.12.4. SWOT Analysis 15.3.12.5. Strategic Overview 15.3.13. Cisco Systems, Inc. 15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.13.2. Product Portfolio 15.3.13.3. Financial Overview 15.3.13.4. SWOT Analysis 15.3.13.5. Strategic Overview
SummaryDigital Health Market – Scope of Report Table of Contents1. Preface1.1. Market Definition and Scope 1.2. Market Segmentation 1.3. Key Research Objectives 1.4. Research Highlights 2. Assumptions and Research Methodology 3. Executive Summary: Global Digital Health Market 4. Market Overview 4.1. Introduction 4.1.1. Segment Definition 4.2. Overview 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. Global Digital Health Market Analysis and Forecast, 2017-2031 4.4.1. Market Revenue Projections (US$ Bn) 5. Key Insights 5.1. Trends 5.1.1. Increase in Adoption of Cloud-based Systems 5.1.2. Virtualization Technologies and Technological Advancements Add New Dimensions to Healthcare IT 5.2. Digital Therapeutic Business, Opportunities, and Entry Barriers for New Market Entrants 5.3. Qualitative Information on Business Models in Digital Health Market 5.4. Traditional Business Model: Challenges to Traditional Business Model 5.5. New Digital Health Business Model 5.6. Adoption of Digital Healthcare, by End-users 5.7. Impact Factor for Digital Therapeutic Demand 5.8. Global Healthcare Expenditure, by Major Countries 5.9. Digital Medicine Business Model 5.10. Factors Increasing Traction of Digital Therapeutic Products 5.10.1. Healthcare Costs 5.10.2. Value-based Payment Models 5.10.3. Venture Funding 5.10.4. Others 6. Global Digital Health Market Analysis and Forecast, by Product 6.1. Introduction & Definition 6.2. Key Findings/Developments 6.3. Market Value Forecast, by Product, 2017-2031 6.3.1. Healthcare Information Systems 6.3.1.1. Clinical Solutions 6.3.1.1.1. EHR/EMR 6.3.1.1.2. Clinical Decision Support System (CDSS) 6.3.1.1.3. Computerized Physician Order Entry (CPOE) 6.3.1.1.4. mHealth 6.3.1.1.4.1. Connected Medical Devices 6.3.1.1.4.2. mHealth Components 6.3.1.1.4.2.1. Fitness App 6.3.1.1.4.2.2. Medical Reference 6.3.1.1.4.2.3. Fitness App 6.3.1.1.4.2.4. Wellness 6.3.1.1.4.2.5. Medical Condition Management 6.3.1.1.4.2.6. Nutrition 6.3.1.1.4.2.7. Remote Consultation 6.3.1.1.4.2.8. Reminders and Alerts 6.3.1.1.4.2.9. Others 6.3.1.1.5. Telehealth 6.3.1.1.6. Population Health Management 6.3.1.1.7. Others 6.3.1.2. Non-clinical Solutions 6.3.2. Wearable Devices 6.3.2.1. Diagnostic and Monitoring Devices 6.3.2.2. Digital Therapeutic Devices 6.3.2.2.1. Pain Management Devices 6.3.2.2.2. Rehabilitation Devices 6.3.2.2.3. Respiratory Therapy Devices 6.3.2.2.4. Insulin Pumps 6.4. Market Attractiveness Analysis, by Product 7. Global Digital Health Market Analysis and Forecast, by Component 7.1. Introduction & Definition 7.2. Key Findings/Developments 7.3. Market Value Forecast, by Component, 2017-2031 7.3.1. Software 7.3.2. Hardware 7.3.3. Services 7.4. Market Attractiveness Analysis, by Component 8. Global Digital Health Market Analysis and Forecast, by End-user 8.1. Introduction & Definition 8.2. Key Findings/Developments 8.3. Market Value Forecast, by End-user, 2017-2031 8.3.1. B2C 8.3.1.1. Patients 8.3.1.2. Caregivers 8.3.2. B2B 8.3.2.1. Providers 8.3.2.2. Payers 8.3.2.3. Employers 8.3.2.4. Pharmaceutical Companies 8.3.2.5. Others 8.4. Market Attractiveness Analysis, by End-user 9. Global Digital Health Market Analysis and Forecast, by Region 9.1. Key Findings 9.2. Market Value Forecast, by Region, 2017-2031 9.2.1. North America 9.2.2. Europe 9.2.3. Asia Pacific 9.2.4. Latin America 9.2.5. Middle East & Africa 9.3. Market Attractiveness Analysis, by Region 10. North America Digital Health Market Analysis and Forecast 10.1. Introduction 10.1.1. Key Findings 10.2. Market Value Forecast, by Product, 2017-2031 10.2.1. Healthcare Information Systems 10.2.1.1. Clinical Solutions 10.2.1.1.1. EHR/EMR 10.2.1.1.2. Clinical Decision Support System (CDSS) 10.2.1.1.3. Computerized Physician Order Entry (CPOE) 10.2.1.1.4. mHealth 10.2.1.1.4.1. Connected Medical Devices 10.2.1.1.4.2. mHealth Components 10.2.1.1.4.2.1. Fitness App 10.2.1.1.4.2.2. Medical Reference 10.2.1.1.4.2.3. Fitness App 10.2.1.1.4.2.4. Wellness 10.2.1.1.4.2.5. Medical Condition Management 10.2.1.1.4.2.6. Nutrition 10.2.1.1.4.2.7. Remote Consultation 10.2.1.1.4.2.8. Reminders and Alerts 10.2.1.1.4.2.9. Others 10.2.1.1.5. Telehealth 10.2.1.1.6. Population Health Management 10.2.1.1.7. Others 10.2.1.2. Non-clinical Solutions 10.2.2. Wearable Devices 10.2.2.1. Diagnostic and Monitoring Devices 10.2.2.2. Digital Therapeutic Devices 10.2.2.2.1. Pain Management Devices 10.2.2.2.2. Rehabilitation Devices 10.2.2.2.3. Respiratory Therapy Devices 10.2.2.2.4. Insulin Pumps 10.3. Market Value Forecast, by Component, 2017-2031 10.3.1. Software 10.3.2. Hardware 10.3.3. Services 10.4. Market Value Forecast, by End-user, 2017-2031 10.4.1. B2C 10.4.1.1. Patients 10.4.1.2. Caregivers 10.4.2. B2B 10.4.2.1. Providers 10.4.2.2. Payers 10.4.2.3. Employers 10.4.2.4. Pharmaceutical Companies 10.4.2.5. Others 10.5. Market Value Forecast, by Country, 2017-2031 10.5.1. U.S. 10.5.2. Canada 10.6. Market Attractiveness Analysis 10.6.1. By Product 10.6.2. By Component 10.6.3. By End-user 10.6.4. By Country 11. Europe Digital Health Market Analysis and Forecast 11.1. Introduction 11.1.1. Key Findings 11.2. Market Value Forecast, by Product, 2017-2031 11.2.1. Healthcare Information Systems 11.2.1.1. Clinical Solutions 11.2.1.1.1. EHR/EMR 11.2.1.1.2. Clinical Decision Support System (CDSS) 11.2.1.1.3. Computerized Physician Order Entry (CPOE) 11.2.1.1.4. mHealth 11.2.1.1.4.1. Connected Medical Devices 11.2.1.1.4.2. mHealth Components 11.2.1.1.4.2.1. Fitness App 11.2.1.1.4.2.2. Medical Reference 11.2.1.1.4.2.3. Fitness App 11.2.1.1.4.2.4. Wellness 11.2.1.1.4.2.5. Medical Condition Management 11.2.1.1.4.2.6. Nutrition 11.2.1.1.4.2.7. Remote Consultation 11.2.1.1.4.2.8. Reminders and Alerts 11.2.1.1.4.2.9. Others 11.2.1.1.5. Telehealth 11.2.1.1.6. Population Health Management 11.2.1.1.7. Others 11.2.1.2. Non-clinical Solutions 11.2.2. Wearable Devices 11.2.2.1. Diagnostic and Monitoring Devices 11.2.2.2. Digital Therapeutic Devices 11.2.2.2.1. Pain Management Devices 11.2.2.2.2. Rehabilitation Devices 11.2.2.2.3. Respiratory Therapy Devices 11.2.2.2.4. Insulin Pumps 11.3. Market Value Forecast, by Component, 2017-2031 11.3.1. Software 11.3.2. Hardware 11.3.3. Services 11.4. Market Value Forecast, by End-user, 2017-2031 11.4.1. B2C 11.4.1.1. Patients 11.4.1.2. Caregivers 11.4.2. B2B 11.4.2.1. Providers 11.4.2.2. Payers 11.4.2.3. Employers 11.4.2.4. Pharmaceutical Companies 11.4.2.5. Others 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031 11.5.1. Germany 11.5.2. U.K. 11.5.3. France 11.5.4. Italy 11.5.5. Spain 11.5.6. Rest of Europe 11.6. Market Attractiveness Analysis 11.6.1. By Product 11.6.2. By Component 11.6.3. By End-user 11.6.4. By Country/Sub-region 12. Asia Pacific Digital Health Market Analysis and Forecast 12.1. Introduction 12.1.1. Key Findings 12.2. Market Value Forecast, by Product, 2017-2031 12.2.1. Healthcare Information Systems 12.2.1.1. Clinical Solutions 12.2.1.1.1. EHR/EMR 12.2.1.1.2. Clinical Decision Support System (CDSS) 12.2.1.1.3. Computerized Physician Order Entry (CPOE) 12.2.1.1.4. mHealth 12.2.1.1.4.1. Connected Medical Devices 12.2.1.1.4.2. mHealth Components 12.2.1.1.4.2.1. Fitness App 12.2.1.1.4.2.2. Medical Reference 12.2.1.1.4.2.3. Fitness App 12.2.1.1.4.2.4. Wellness 12.2.1.1.4.2.5. Medical Condition Management 12.2.1.1.4.2.6. Nutrition 12.2.1.1.4.2.7. Remote Consultation 12.2.1.1.4.2.8. Reminders and Alerts 12.2.1.1.4.2.9. Others 12.2.1.1.5. Telehealth 12.2.1.1.6. Population Health Management 12.2.1.1.7. Others 12.2.1.2. Non-clinical Solutions 12.2.2. Wearable Devices 12.2.2.1. Diagnostic and Monitoring Devices 12.2.2.2. Digital Therapeutic Devices 12.2.2.2.1. Pain Management Devices 12.2.2.2.2. Rehabilitation Devices 12.2.2.2.3. Respiratory Therapy Devices 12.2.2.2.4. Insulin Pumps 12.3. Market Value Forecast, by Component, 2017-2031 12.3.1. Software 12.3.2. Hardware 12.3.3. Services 12.4. Market Value Forecast, by End-user, 2017-2031 12.4.1. B2C 12.4.1.1. Patients 12.4.1.2. Caregivers 12.4.2. B2B 12.4.2.1. Providers 12.4.2.2. Payers 12.4.2.3. Employers 12.4.2.4. Pharmaceutical Companies 12.4.2.5. Others 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031 12.5.1. China 12.5.2. India 12.5.3. Japan 12.5.4. Australia & New Zealand 12.5.5. Rest of Asia Pacific 12.6. Market Attractiveness Analysis 12.6.1. By Product 12.6.2. By Component 12.6.3. By End-user 12.6.4. By Country/Sub-region 13. Latin America Digital Health Market Analysis and Forecast 13.1. Introduction 13.1.1. Key Findings 13.2. Market Value Forecast, by Product, 2017-2031 13.2.1. Healthcare Information Systems 13.2.1.1. Clinical Solutions 13.2.1.1.1. EHR/EMR 13.2.1.1.2. Clinical Decision Support System (CDSS) 13.2.1.1.3. Computerized Physician Order Entry (CPOE) 13.2.1.1.4. mHealth 13.2.1.1.4.1. Connected Medical Devices 13.2.1.1.4.2. mHealth Components 13.2.1.1.4.2.1. Fitness App 13.2.1.1.4.2.2. Medical Reference 13.2.1.1.4.2.3. Fitness App 13.2.1.1.4.2.4. Wellness 13.2.1.1.4.2.5. Medical Condition Management 13.2.1.1.4.2.6. Nutrition 13.2.1.1.4.2.7. Remote Consultation 13.2.1.1.4.2.8. Reminders and Alerts 13.2.1.1.4.2.9. Others 13.2.1.1.5. Telehealth 13.2.1.1.6. Population Health Management 13.2.1.1.7. Others 13.2.1.2. Non-clinical Solutions 13.2.2. Wearable Devices 13.2.2.1. Diagnostic and Monitoring Devices 13.2.2.2. Digital Therapeutic Devices 13.2.2.2.1. Pain Management Devices 13.2.2.2.2. Rehabilitation Devices 13.2.2.2.3. Respiratory Therapy Devices 13.2.2.2.4. Insulin Pumps 13.3. Market Value Forecast, by Component, 2017-2031 13.3.1. Software 13.3.2. Hardware 13.3.3. Services 13.4. Market Value Forecast, by End-user, 2017-2031 13.4.1. B2C 13.4.1.1. Patients 13.4.1.2. Caregivers 13.4.2. B2B 13.4.2.1. Providers 13.4.2.2. Payers 13.4.2.3. Employers 13.4.2.4. Pharmaceutical Companies 13.4.2.5. Others 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031 13.5.1. Brazil 13.5.2. Mexico 13.5.3. Rest of Latin America 13.6. Market Attractiveness Analysis 13.6.1. By Product 13.6.2. By Component 13.6.3. By End-user 13.6.4. By Country/Sub-region 14. Middle East & Africa Digital Health Market Analysis and Forecast 14.1. Introduction 14.1.1. Key Findings 14.2. Market Value Forecast, by Product, 2017-2031 14.2.1. Healthcare Information Systems 14.2.1.1. Clinical Solutions 14.2.1.1.1. EHR/EMR 14.2.1.1.2. Clinical Decision Support System (CDSS) 14.2.1.1.3. Computerized Physician Order Entry (CPOE) 14.2.1.1.4. mHealth 14.2.1.1.4.1. Connected Medical Devices 14.2.1.1.4.2. mHealth Components 14.2.1.1.4.2.1. Fitness App 14.2.1.1.4.2.2. Medical Reference 14.2.1.1.4.2.3. Fitness App 14.2.1.1.4.2.4. Wellness 14.2.1.1.4.2.5. Medical Condition Management 14.2.1.1.4.2.6. Nutrition 14.2.1.1.4.2.7. Remote Consultation 14.2.1.1.4.2.8. Reminders and Alerts 14.2.1.1.4.2.9. Others 14.2.1.1.5. Telehealth 14.2.1.1.6. Population Health Management 14.2.1.1.7. Others 14.2.1.2. Non-clinical Solutions 14.2.2. Wearable Devices 14.2.2.1. Diagnostic and Monitoring Devices 14.2.2.2. Digital Therapeutic Devices 14.2.2.2.1. Pain Management Devices 14.2.2.2.2. Rehabilitation Devices 14.2.2.2.3. Respiratory Therapy Devices 14.2.2.2.4. Insulin Pumps 14.3. Market Value Forecast, by Component, 2017-2031 14.3.1. Software 14.3.2. Hardware 14.3.3. Services 14.4. Market Value Forecast, by End-user, 2017-2031 14.4.1. B2C 14.4.1.1. Patients 14.4.1.2. Caregivers 14.4.2. B2B 14.4.2.1. Providers 14.4.2.2. Payers 14.4.2.3. Employers 14.4.2.4. Pharmaceutical Companies 14.4.2.5. Others 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031 14.5.1. GCC Countries 14.5.2. South Africa 14.5.3. Rest of Middle East & Africa 14.6. Market Attractiveness Analysis 14.6.1. By Product 14.6.2. By Component 14.6.3. By End-user 14.6.4. By Country/Sub-region 15. Competition Landscape 15.1. Market Player - Competition Matrix (by Tier and Size of Companies) 15.2. Market Share Analysis, by Company, 2022 15.3. Company Profiles 15.3.1. Agfa-Gevaert N.V. 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.1.2. Product Portfolio 15.3.1.3. Financial Overview 15.3.1.4. SWOT Analysis 15.3.1.5. Strategic Overview 15.3.2. Cerner Corporation 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.2.2. Product Portfolio 15.3.2.3. Financial Overview 15.3.2.4. SWOT Analysis 15.3.2.5. Strategic Overview 15.3.3. Allscripts Healthcare Solutions, Inc. 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.3.2. Product Portfolio 15.3.3.3. Financial Overview 15.3.3.4. SWOT Analysis 15.3.3.5. Strategic Overview 15.3.4. McKesson Corporation 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.4.2. Product Portfolio 15.3.4.3. Financial Overview 15.3.4.4. SWOT Analysis 15.3.4.5. Strategic Overview 15.3.5. Philips Healthcare 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.5.2. Product Portfolio 15.3.5.3. Financial Overview 15.3.5.4. SWOT Analysis 15.3.5.5. Strategic Overview 15.3.6. GE Healthcare 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.6.2. Product Portfolio 15.3.6.3. Financial Overview 15.3.6.4. SWOT Analysis 15.3.6.5. Strategic Overview 15.3.7. Siemens Healthineers 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.7.2. Product Portfolio 15.3.7.3. Financial Overview 15.3.7.4. SWOT Analysis 15.3.7.5. Strategic Overview 15.3.8. Epic Systems Corporation. 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.8.2. Product Portfolio 15.3.8.3. Financial Overview 15.3.8.4. SWOT Analysis 15.3.8.5. Strategic Overview 15.3.9. Merative 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.9.2. Product Portfolio 15.3.9.3. Financial Overview 15.3.9.4. SWOT Analysis 15.3.9.5. Strategic Overview 15.3.10. Alphabet Inc. 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.10.2. Product Portfolio 15.3.10.3. Financial Overview 15.3.10.4. SWOT Analysis 15.3.10.5. Strategic Overview 15.3.11. Qualcomm, Inc. 15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.11.2. Product Portfolio 15.3.11.3. Financial Overview 15.3.11.4. SWOT Analysis 15.3.11.5. Strategic Overview 15.3.12. UnitedHealth Group (Optum) 15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.12.2. Product Portfolio 15.3.12.3. Financial Overview 15.3.12.4. SWOT Analysis 15.3.12.5. Strategic Overview 15.3.13. Cisco Systems, Inc. 15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.13.2. Product Portfolio 15.3.13.3. Financial Overview 15.3.13.4. SWOT Analysis 15.3.13.5. Strategic Overview
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
Transparency Market Research 社の最新刊レポート
本レポートと同じKEY WORD(healthcare)の最新刊レポート
よくあるご質問Transparency Market Research社はどのような調査会社ですか?トレンスペアレンシーマーケットリサーチ(Transparency Market Research /TMR)は市場参入やホワイトスペースの特定、新商品や新サービスの立ち上げ、戦略的M&Aなどの実現のた... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/12 10:26 154.83 円 165.45 円 201.96 円 |